The ambiguity of adverse drug reactions View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1977-03

AUTHORS

J. Koch-Weser, E. M. Sellers, R. Zacest

ABSTRACT

Three clinical pharmacologists independently evaluated 500 untoward clinical events reported by physicians as adverse drug reactions (ADRs). They often disagreed with the reporting physicians and with each other. They judged 14.4-28.2% of the events to be definite, 26.4-38.0% probable, 21.4-31.0% possible and 15.8-28.2% of the events to be definite, 26.4-38.0% probable, 21.4-31.0% possible and 15.8-28.2% unlikely ADRs. In their opinion 19.1-32.4% of the drugs blamed were definitely, 29.8-34.4% probably, 24.9-36.7% possibly and 8.4-14.5% not responsible for the adverse reactions. Evaluators disagreed among themselves about the drug most likely to have been responsible in 36.4% of the events, about ADRs causing hospital admission in 56.8%, about severe ADR morbidity in 55.8%, about ADR prolongation of hospitalization in 67.3% and ADR prolongation of hospitalization in 67.3% and about ADR contribution to death in 71.0%. The divergence of judgements suggests that suspected ADRs are usually ambiguous clinical events, and that incidence, severity, medical consequences and cost of ADRs can only be estimated. More... »

PAGES

75-78

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/bf00562895

DOI

http://dx.doi.org/10.1007/bf00562895

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1023387813

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/837969


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug-Related Side Effects and Adverse Reactions", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Evaluation Studies as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hospitals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Massachusetts General Hospital", 
          "id": "https://www.grid.ac/institutes/grid.32224.35", 
          "name": [
            "Clinical Pharmacology Unit, Massachusetts General Hospital, Boston, Massachusetts, U.S.A.", 
            "Centre de Recherche Merrell International, 16, rue d'Ankara, F-67084, Strasbourg Cedex, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Koch-Weser", 
        "givenName": "J.", 
        "id": "sg:person.01040123737.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01040123737.56"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Massachusetts General Hospital", 
          "id": "https://www.grid.ac/institutes/grid.32224.35", 
          "name": [
            "Clinical Pharmacology Unit, Massachusetts General Hospital, Boston, Massachusetts, U.S.A."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sellers", 
        "givenName": "E. M.", 
        "id": "sg:person.066174270.96", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.066174270.96"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Massachusetts General Hospital", 
          "id": "https://www.grid.ac/institutes/grid.32224.35", 
          "name": [
            "Clinical Pharmacology Unit, Massachusetts General Hospital, Boston, Massachusetts, U.S.A."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zacest", 
        "givenName": "R.", 
        "id": "sg:person.0106271044.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0106271044.16"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1056/nejm196901022800105", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003126722"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.1975.03260250028021", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004904607"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cpt1976195part1489", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006003488"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm196809262791304", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009875946"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cpt1974161part1110", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015729568"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm197408082910610", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034376740"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.1976.03270060025021", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035595400"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.234.12.1236", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1054133020"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.236.6.575", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1054134538"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7326/0003-4819-60-2-255", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1073722369"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1080630586", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1977-03", 
    "datePublishedReg": "1977-03-01", 
    "description": "Three clinical pharmacologists independently evaluated 500 untoward clinical events reported by physicians as adverse drug reactions (ADRs). They often disagreed with the reporting physicians and with each other. They judged 14.4-28.2% of the events to be definite, 26.4-38.0% probable, 21.4-31.0% possible and 15.8-28.2% of the events to be definite, 26.4-38.0% probable, 21.4-31.0% possible and 15.8-28.2% unlikely ADRs. In their opinion 19.1-32.4% of the drugs blamed were definitely, 29.8-34.4% probably, 24.9-36.7% possibly and 8.4-14.5% not responsible for the adverse reactions. Evaluators disagreed among themselves about the drug most likely to have been responsible in 36.4% of the events, about ADRs causing hospital admission in 56.8%, about severe ADR morbidity in 55.8%, about ADR prolongation of hospitalization in 67.3% and ADR prolongation of hospitalization in 67.3% and about ADR contribution to death in 71.0%. The divergence of judgements suggests that suspected ADRs are usually ambiguous clinical events, and that incidence, severity, medical consequences and cost of ADRs can only be estimated.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/bf00562895", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1054337", 
        "issn": [
          "0031-6970", 
          "1432-1041"
        ], 
        "name": "European Journal of Clinical Pharmacology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "11"
      }
    ], 
    "name": "The ambiguity of adverse drug reactions", 
    "pagination": "75-78", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "6f6d214136fc89884d680bd9d4c82415e3020c3c06a8b89125ed1909f099d2de"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "837969"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "1256165"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/bf00562895"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1023387813"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/bf00562895", 
      "https://app.dimensions.ai/details/publication/pub.1023387813"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T13:55", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000371_0000000371/records_130814_00000002.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/BF00562895"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf00562895'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf00562895'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf00562895'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf00562895'


 

This table displays all metadata directly associated to this object as RDF triples.

132 TRIPLES      21 PREDICATES      44 URIs      25 LITERALS      13 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/bf00562895 schema:about N22184c1b2fd94aafa4bccac015bad003
2 N337528e366b94deea6c051cfa586f8e3
3 N8a15f1dcc21646ab932129efc1398558
4 Nbb3198c1db9d4e37b61974757eefd04c
5 anzsrc-for:11
6 anzsrc-for:1103
7 schema:author N9b569b6214814c7596ca94af0ba27800
8 schema:citation https://app.dimensions.ai/details/publication/pub.1080630586
9 https://doi.org/10.1001/jama.1975.03260250028021
10 https://doi.org/10.1001/jama.1976.03270060025021
11 https://doi.org/10.1001/jama.234.12.1236
12 https://doi.org/10.1001/jama.236.6.575
13 https://doi.org/10.1002/cpt1974161part1110
14 https://doi.org/10.1002/cpt1976195part1489
15 https://doi.org/10.1056/nejm196809262791304
16 https://doi.org/10.1056/nejm196901022800105
17 https://doi.org/10.1056/nejm197408082910610
18 https://doi.org/10.7326/0003-4819-60-2-255
19 schema:datePublished 1977-03
20 schema:datePublishedReg 1977-03-01
21 schema:description Three clinical pharmacologists independently evaluated 500 untoward clinical events reported by physicians as adverse drug reactions (ADRs). They often disagreed with the reporting physicians and with each other. They judged 14.4-28.2% of the events to be definite, 26.4-38.0% probable, 21.4-31.0% possible and 15.8-28.2% of the events to be definite, 26.4-38.0% probable, 21.4-31.0% possible and 15.8-28.2% unlikely ADRs. In their opinion 19.1-32.4% of the drugs blamed were definitely, 29.8-34.4% probably, 24.9-36.7% possibly and 8.4-14.5% not responsible for the adverse reactions. Evaluators disagreed among themselves about the drug most likely to have been responsible in 36.4% of the events, about ADRs causing hospital admission in 56.8%, about severe ADR morbidity in 55.8%, about ADR prolongation of hospitalization in 67.3% and ADR prolongation of hospitalization in 67.3% and about ADR contribution to death in 71.0%. The divergence of judgements suggests that suspected ADRs are usually ambiguous clinical events, and that incidence, severity, medical consequences and cost of ADRs can only be estimated.
22 schema:genre research_article
23 schema:inLanguage en
24 schema:isAccessibleForFree false
25 schema:isPartOf N2cb3193ae19946a9a0da9e95e99708c0
26 Nbf84b3902d794ccdbc8cacf9bc0efa3c
27 sg:journal.1054337
28 schema:name The ambiguity of adverse drug reactions
29 schema:pagination 75-78
30 schema:productId N24bd31390cd6459686317a2b1038fa52
31 N545b4f909db140668982d60c1abd7ba8
32 N918e8a1f36cc4bddb4b14bbe8cb67dc7
33 Na2168b3d97fd4fef9ac7a64061e9fdde
34 Nc4a2107d6a674464a8fec69b5fe2a19f
35 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023387813
36 https://doi.org/10.1007/bf00562895
37 schema:sdDatePublished 2019-04-11T13:55
38 schema:sdLicense https://scigraph.springernature.com/explorer/license/
39 schema:sdPublisher N750f9634ae8a4fef8c503436fb3e6c85
40 schema:url http://link.springer.com/10.1007/BF00562895
41 sgo:license sg:explorer/license/
42 sgo:sdDataset articles
43 rdf:type schema:ScholarlyArticle
44 N123d7e9417a94dfab9103c0da89769b6 rdf:first sg:person.066174270.96
45 rdf:rest N96526a7fb57f44dc86f40acc3fd5e759
46 N22184c1b2fd94aafa4bccac015bad003 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
47 schema:name Drug-Related Side Effects and Adverse Reactions
48 rdf:type schema:DefinedTerm
49 N24bd31390cd6459686317a2b1038fa52 schema:name pubmed_id
50 schema:value 837969
51 rdf:type schema:PropertyValue
52 N2cb3193ae19946a9a0da9e95e99708c0 schema:volumeNumber 11
53 rdf:type schema:PublicationVolume
54 N337528e366b94deea6c051cfa586f8e3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
55 schema:name Evaluation Studies as Topic
56 rdf:type schema:DefinedTerm
57 N545b4f909db140668982d60c1abd7ba8 schema:name readcube_id
58 schema:value 6f6d214136fc89884d680bd9d4c82415e3020c3c06a8b89125ed1909f099d2de
59 rdf:type schema:PropertyValue
60 N750f9634ae8a4fef8c503436fb3e6c85 schema:name Springer Nature - SN SciGraph project
61 rdf:type schema:Organization
62 N8a15f1dcc21646ab932129efc1398558 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
63 schema:name Hospitals
64 rdf:type schema:DefinedTerm
65 N918e8a1f36cc4bddb4b14bbe8cb67dc7 schema:name doi
66 schema:value 10.1007/bf00562895
67 rdf:type schema:PropertyValue
68 N96526a7fb57f44dc86f40acc3fd5e759 rdf:first sg:person.0106271044.16
69 rdf:rest rdf:nil
70 N9b569b6214814c7596ca94af0ba27800 rdf:first sg:person.01040123737.56
71 rdf:rest N123d7e9417a94dfab9103c0da89769b6
72 Na2168b3d97fd4fef9ac7a64061e9fdde schema:name dimensions_id
73 schema:value pub.1023387813
74 rdf:type schema:PropertyValue
75 Nbb3198c1db9d4e37b61974757eefd04c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
76 schema:name Humans
77 rdf:type schema:DefinedTerm
78 Nbf84b3902d794ccdbc8cacf9bc0efa3c schema:issueNumber 2
79 rdf:type schema:PublicationIssue
80 Nc4a2107d6a674464a8fec69b5fe2a19f schema:name nlm_unique_id
81 schema:value 1256165
82 rdf:type schema:PropertyValue
83 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
84 schema:name Medical and Health Sciences
85 rdf:type schema:DefinedTerm
86 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
87 schema:name Clinical Sciences
88 rdf:type schema:DefinedTerm
89 sg:journal.1054337 schema:issn 0031-6970
90 1432-1041
91 schema:name European Journal of Clinical Pharmacology
92 rdf:type schema:Periodical
93 sg:person.01040123737.56 schema:affiliation https://www.grid.ac/institutes/grid.32224.35
94 schema:familyName Koch-Weser
95 schema:givenName J.
96 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01040123737.56
97 rdf:type schema:Person
98 sg:person.0106271044.16 schema:affiliation https://www.grid.ac/institutes/grid.32224.35
99 schema:familyName Zacest
100 schema:givenName R.
101 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0106271044.16
102 rdf:type schema:Person
103 sg:person.066174270.96 schema:affiliation https://www.grid.ac/institutes/grid.32224.35
104 schema:familyName Sellers
105 schema:givenName E. M.
106 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.066174270.96
107 rdf:type schema:Person
108 https://app.dimensions.ai/details/publication/pub.1080630586 schema:CreativeWork
109 https://doi.org/10.1001/jama.1975.03260250028021 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004904607
110 rdf:type schema:CreativeWork
111 https://doi.org/10.1001/jama.1976.03270060025021 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035595400
112 rdf:type schema:CreativeWork
113 https://doi.org/10.1001/jama.234.12.1236 schema:sameAs https://app.dimensions.ai/details/publication/pub.1054133020
114 rdf:type schema:CreativeWork
115 https://doi.org/10.1001/jama.236.6.575 schema:sameAs https://app.dimensions.ai/details/publication/pub.1054134538
116 rdf:type schema:CreativeWork
117 https://doi.org/10.1002/cpt1974161part1110 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015729568
118 rdf:type schema:CreativeWork
119 https://doi.org/10.1002/cpt1976195part1489 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006003488
120 rdf:type schema:CreativeWork
121 https://doi.org/10.1056/nejm196809262791304 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009875946
122 rdf:type schema:CreativeWork
123 https://doi.org/10.1056/nejm196901022800105 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003126722
124 rdf:type schema:CreativeWork
125 https://doi.org/10.1056/nejm197408082910610 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034376740
126 rdf:type schema:CreativeWork
127 https://doi.org/10.7326/0003-4819-60-2-255 schema:sameAs https://app.dimensions.ai/details/publication/pub.1073722369
128 rdf:type schema:CreativeWork
129 https://www.grid.ac/institutes/grid.32224.35 schema:alternateName Massachusetts General Hospital
130 schema:name Centre de Recherche Merrell International, 16, rue d'Ankara, F-67084, Strasbourg Cedex, France
131 Clinical Pharmacology Unit, Massachusetts General Hospital, Boston, Massachusetts, U.S.A.
132 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...